Specific T Cell Frequency and Cytokine Expression Profile Do Not Correlate with Protection against Tuberculosis after Bacillus Calmette-Guérin Vaccination of Newborns

Only a Subset of Phosphoantigen-Responsive  9 2 T Cells Mediate Protective Tuberculosis Immunity

(2014) C. T. Spencer et al.   JOURNAL OF IMMUNOLOGY

Bacillus Calmette-Guerin Vaccination of Human Newborns Induces T Cells with Complex Cytokine and Phenotypic Profiles

(2014) A. P. Soares et al.   JOURNAL OF IMMUNOLOGY

CD4 and CD8 T-Cell Responses to Mycobacterial Antigens in African Children

(2010) Nontobeko G. Tena-Coki et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

The Novel Tuberculosis Vaccine, AERAS-402, Induces Robust and Polyfunctional CD4+and CD8+T Cells in Adults

(2010) Brian Abel et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

IFNG +874T/A polymorphism and cytokine plasma levels are associated with susceptibility to Mycobacterium tuberculosis infection and clinical manifestation of tuberculosis

(2010) Antonio C.R. Vallinoto et al.   HUMAN IMMUNOLOGY

Mycobacterium tuberculosis Peptides Presented by HLA-E Molecules Are Targets for Human CD8+ T-Cells with Cytotoxic as well as Regulatory Activity

(2010) Simone A. Joosten et al.   PLoS Pathogens

Safety and Immunogenicity of a New Tuberculosis Vaccine, MVA85A, inMycobacterium tuberculosis–infected Individuals

(2009) Clare R. Sander et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Reduced Th17 Response in Patients with Tuberculosis Correlates with IL-6R Expression on CD4+T Cells

(2009) Xinchun Chen et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Complex nature of SNP genotype effects on gene expression in primary human leucocytes

(2009) Graham A Heap et al.   BMC Medical Genomics

Pattern and diversity of cytokine production differentiates betweenMycobacterium tuberculosisinfection and disease

(2009) Jayne S. Sutherland et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Anti-TNF immunotherapy reduces CD8+ T cell–mediated antimicrobial activity against Mycobacterium tuberculosis in humans

(2009) Heiko Bruns et al.   JOURNAL OF CLINICAL INVESTIGATION

Betulin Is a Potent Anti-Tumor Agent that Is Enhanced by Cholesterol

(2009) Franziska B. Mullauer et al.   PLoS One

Defined tuberculosis vaccine, Mtb72F/AS02A, evidence of protection in cynomolgus monkeys

(2009) S. G. Reed et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Delaying BCG vaccination from birth to 10 weeks of age may result in an enhanced memory CD4 T cell response

(2009) Benjamin M.N. Kagina et al.   VACCINE

A Critical Role for CD8 T Cells in a Nonhuman Primate Model of Tuberculosis

(2009) Crystal Y. Chen et al.   PLoS Pathogens

Delayed protection by ESAT-6–specific effector CD4+T cells after airborneM. tuberculosisinfection

(2008) Alena M. Gallegos et al.   JOURNAL OF EXPERIMENTAL MEDICINE

A New Recombinant Bacille Calmette‐Guérin Vaccine Safely Induces Significantly Enhanced Tuberculosis‐Specific Immunity in Human Volunteers

(2008) Daniel F. Hoft et al.   JOURNAL OF INFECTIOUS DISEASES

Safety and Immunogenicity of a New Tuberculosis Vaccine, MVA85A, in Healthy Adults in South Africa

(2008) Tony Hawkridge et al.   JOURNAL OF INFECTIOUS DISEASES